TP53 and sarcoma: Thus, the G2-M transition is also defective in p53-null sarcomas expressing only L466A MDM2, suggesting MDM2 E3 ligase activity is specifically required for timely progression through the G2/M phase in the absence of p53, both in vitro and in vivo in different cell types.